In situ hybridization and immunohistochemistry were used to determine the cellular expression of Drgal1-L2. No
drgal1-L2 mRNA or protein was detected in the unlesioned retinas, in the ventral halves of light-damaged retinas, or in the circumferential marginal zones (data not shown). In contrast, in the light-lesioned dorsal retina, in situ hybridization showed that
drgal1-L2 was expressed in radial columns of cells in the inner nuclear layer (INL) and ONL, beneath the injured/dying photoreceptors (
Fig. 2). Drgal1-L2-specific antibodies
27 labeled a similar pattern of cells that were also PCNA positive, confirming that the Drgal1-L2 protein is expressed by injury-induced neural progenitors (
Figs. 3a–e). To test whether Gal-
Drgal1-L2 is expressed in proliferating Müller glia, PCNA immunostaining was combined with in situ hybridization of
drgal1-L2 mRNA on retinal sections from the Tg(
gfap:GFP)
mi2001 zebrafish. Each signal colocalized to the same cells, confirming that
drgal1-L2 is expressed by proliferating Müller glia and their progeny (
Figs. 3f–j). A few Drgal1-L2–positive,
gfap-GFP–negative cells were also observed. Using the microglial specific antibody 4C4,
9 these cells were identified as microglia (
Figs. 4f–h). A time course of light damage demonstrated that Drgal1-L2 is expressed as early as 24 hours after light onset in PCNA-positive Müller glia within the INL (data not shown). As evidenced by immunostaining, upregulated expression of Drgal1-L2 protein persists up to 7 days after light onset (see
Fig. 4).